ArticleJournal of medical imaging (Bellingham, Wash.)2025
MD-SA2: optimizing Segment Anything 2 for multimodal, depth-aware brain tumor segmentation in sub-Saharan populations.
Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Machine learning algorithms are emerging as valuable aides for radiologists in medical image segmentation due to their accuracy and speed. However, existing approaches, including both conventional machine learning and Segment Anything (SA)-based models, face challenges with the complex, multimodal, and varied quality of magnetic resonance imaging (MRI) scan images used for brain tumor segmentation. To address these challenges, we propose MD-SA2, adapting Segment Anything 2 (SA2) to medical image segmentation and introducing a lightweight U-Net "aggregator" model. Approach: Various modifications are incorporated to enhance segmentation accuracy and throughput. SA2 is first customized and fine-tuned for greater efficiency than the original Segment Anything. Slices from multiple image modalities are concatenated for input into the image encoder to improve the delineation of tumor subtypes. In addition, a lightweight U-Net aggregator model is integrated with SA2 to introduce depth awareness. The 2023 BraTS-Africa dataset, containing low-resolution MRI images from 60 sub-Saharan patients, is used to evaluate the algorithm's performance. Results: MD-SA2 attains notable improvements over existing approaches under challenging data circumstances. It achieves a tenfold cross-validated, statistically significant improvement over current methods with a 0.7893 Dice coefficient. It also reaches a higher Intersection over Union and lower 95% Hausdorff distance metrics. An ablation study verifies the impact of key components. Conclusions: MD-SA2 displays strong potential for supporting the diagnosis and treatment planning of brain tumors. It may contribute to narrowing health inequities, especially in medically underserved areas where data quantity and quality limitations reduce the efficacy of traditional automated approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.